3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
7
OTHER
4
NIH
2
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
42
Triple Negative Breast Neoplasms
9
Neoplasm Metastasis
4
Hormone Receptor Positive Advanced Breast Cancer
3
HER2-positive Breast Cancer
3
Recurrence
2
Advanced Breast Cancer
2
Skin Diseases
1
Radiation Injuries
1
Pathologic Complete Response
1
Neoplasms by Site
1
Lung Neoplasms
1
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
1
Heart Injuries
1
Cardiovascular Diseases
1
Carcinoma, Ductal, Breast
1
Breast Diseases
1
Breast Cancer Recurrent
1
Brain Neoplasms
1
Interventions
Docetaxel
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Skin Diseases
×
Breast
×
Clear all
NCT01917279
2020-07-23
CAMELLIA
ChineseAMS
Phase 3
Unknown
280 enrolled